Urinary Excretion of Type I Collagen Degradation Products in Healthy Women and Osteoporotic Patients with Vertebral and Hip Fractures

1998 ◽  
Vol 62 (1) ◽  
pp. 36-39 ◽  
Author(s):  
H. Hoshino ◽  
M. Takahashi ◽  
K. Kushida ◽  
T. Ohishi ◽  
T. Inoue
1994 ◽  
Vol 40 (11) ◽  
pp. 2022-2025 ◽  
Author(s):  
M Bonde ◽  
P Qvist ◽  
C Fledelius ◽  
B J Riis ◽  
C Christiansen

Abstract An enzyme-linked immunosorbent assay (ELISA) for measuring type I collagen degradation products in urine < 3 h was evaluated. The measuring range was 0.5-10.5 mg/L with a detection limit of 0.2 mg/L. Within-run and total CVs were 5.3% and 6.6%, respectively. Analytical recovery averaged 100%. The mean (+/- SD) concentrations in urine samples from a healthy premenopausal population (n = 102) were 250 +/- 110 mg/mol creatinine (Cr). A group of healthy postmenopausal women (n = 410) gave a mean value of 416 +/- 189 mg/mol Cr. Values obtained in the ELISA correlated well (r = 0.83) to HPLC values for the established bone resorption marker deoxypyridinoline (n = 214), slightly better than the correlation to hydroxyproline measurements (r = 0.78, n = 421). We conclude that the assay described here presents a useful tool for further elucidating the importance of type I collagen degradation products in urine.


2005 ◽  
Vol 24 (1) ◽  
pp. 63-70 ◽  
Author(s):  
M. Fichter ◽  
U. Körner ◽  
J. Schömburg ◽  
L. Jennings ◽  
A. A. Cole ◽  
...  

1973 ◽  
Vol 12 (1) ◽  
pp. 303-312 ◽  
Author(s):  
Yoshinori Kuboki ◽  
Hitoyata Shimokawa ◽  
Toshio Ono ◽  
Satoshi Sasaki

Bone ◽  
1989 ◽  
Vol 10 (6) ◽  
pp. 471 ◽  
Author(s):  
BM Thomson ◽  
SJ Atkinson ◽  
AM McGarrity ◽  
RM Hembry ◽  
JJ Reynolds ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document